title: [The enhancement of protein degradation systems exerts therapeutic effects in the polyglutamine-mediated motor neuron disease].
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Adachi
mesh_terms: D000726:Androgen Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001343:Autophagy / Q000187:drug effects; D004195:Disease Models, Animal; D005960:Glucosides / Q000494:pharmacology / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D016729:Leuprolide / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D018832:Molecular Chaperones / Q000494:pharmacology / Q000627:therapeutic use; D058990:Molecular Targeted Therapy; D039821:Monoterpenes / Q000494:pharmacology / Q000627:therapeutic use; D016472:Motor Neuron Disease; D020966:Muscular Disorders, Atrophic / Q000209:etiology / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D010455:Peptides; D008517:Phytotherapy; D059748:Proteolysis / Q000187:drug effects; D006027:Glycosides
chemical_list: D000726:Androgen Antagonists; D005960:Glucosides; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide; D018832:Molecular Chaperones; D039821:Monoterpenes; D010455:Peptides; C015423:peoniflorin; D006027:Glycosides; C097188:polyglutamine